Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018
Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012
Features of tuberculosis incidence and clinical forms for sarcoidosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 202s Year: 2004
The prevalence and clinical implications of bronchiectasis in patients with sarcoidosis Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019
Prevalence and impact of WHO group 3 pulmonary hypertension in advanced idiopathic nonspecific interstitial pneumonia Source: Eur Respir J, 52 (1) 1800545; 10.1183/13993003.00545-2018 Year: 2018
Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
The prevalence and subtypes of interstitial lung disease in polymyositis and dermatomyositis patients Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2013; 42: 750-757 Year: 2013
Prevalence and prognosis of unclassifiable interstitial lung disease Source: Eur Respir J 2014; 43: 1529-1530 Year: 2014
Incidence, clinical pictures and courses of patients with MPO-ANCA positive interstitial pneumonia (IP) of unknown etiology Source: Eur Respir J 2004; 24: Suppl. 48, 505s Year: 2004
Predictors of objective cough in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019
Characteristics of the patients with sarcoidosis diagnosed by labial biopsy Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Biopsy documented idiopathic interstitial pneumonias - Analysis of diagnostic yield, survival and mortality over 9 years Source: Annual Congress 2013 –Interventional procedures for diagnosis of diffuse lung diseases and peripheral pulmonary lesions Year: 2013
Incidence of coeliac disease in patients with sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 107s Year: 2001
Significance of abnormal autoantibodies in patients presenting with IPF Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012
Long-term outcome of 53 patients with anti-Jo-1 antibody-positive interstitial lung disease Source: International Congress 2017 – Rare diseases Year: 2017
The gender difference in prevalence of digital clubbing among patients with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 429s Year: 2007
Prevalence of active smokers among 49 patients affected by interstial lung diseases at two referral centers Source: International Congress 2015 – Interstitial lung diseases I Year: 2015
Survival after respiratory hospitalization in patients with idiopathic chronic fibrosing interstitial pneumonia Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias? Year: 2018